Literature DB >> 19676150

Precision performance at low levels and 99th percentile concentration of the Access AccuTnl assay on two different platforms.

Martina Zaninotto1, Monica Maria Mion, Enrica Novello, Marco Moretti, Ernesto Delprete, Marco Bruno Rocchi, Davide Sisti, Mario Plebani.   

Abstract

BACKGROUND: Cardiac troponins currently represent the preferred biomarkers for the detection of myocardial necrosis. The objective of the present study was to compare the performance of the Access AccuTnl assay (Beckman Coulter) measured on two different platforms, the UniCel Dxl 800 and the Access 2 (Beckman Coulter). In particular, the serum cardiac troponin I (cTnl) concentration corresponding to 10% coefficient of variation (CV), the cTnl assay minimum detectable concentration (MDC), and the serum cTnl 99th percentile in healthy subjects were calculated.
METHODS: The Access AccuTnl is a paramagnetic particle chemiluminescent immunoassay. Imprecision profiles were determined according to the Clinical and Laboratory Standards Institute EP5-A protocol using serum pools. The MDC was calculated as mean +3 SD of 20 determinations of the zero calibrator during one run. The 99th percentile was determined analyzing serum samples from 679 healthy blood donors (523 males, 156 females; 18-71 years old).
RESULTS: cTnl concentrations are given in microg/L. 10% CV values (95% confidence interval, CI) were 0.0577 (0.0467-0.0750) (UniCel Dxl 800) and 0.0486 (0.0255-0.0596) (Access 2). MDC values were 0.011 (UniCel Dxl 800) and 0.012 (Access 2). The 99th percentile (95% CI) value was 0.0340 (0.0298-0.0410).
CONCLUSIONS: Our data confirm the reliability of the evaluated cTnl assay and demonstrate the comparability of the cTnl values between the platforms studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19676150     DOI: 10.1515/cclm.2009.080

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners.

Authors:  Giuseppe Lippi; Federico Schena; Gian Luca Salvagno; Cantor Tarperi; Rosalia Aloe; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Predictive significance of detectable cardiac troponin I measured with a contemporary-sensitive assay in a real life experience.

Authors:  Laura Bonfanti; Giuseppe Lippi; Irene Ciullo; Tiziana Meschi; Andrea Ticinesi; Rosalia Aloe; Francesco Di Spigno; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-07

Review 3.  High-sensitivity cardiac troponins in everyday clinical practice.

Authors:  Johannes Mair
Journal:  World J Cardiol       Date:  2014-04-26

4.  A modified HEART risk score in chest pain patients with suspected non-ST-segment elevation acute coronary syndrome.

Authors:  Chun-Peng Ma; Xiao Wang; Qing-Sheng Wang; Xiao-Li Liu; Xiao-Nan He; Shao-Ping Nie
Journal:  J Geriatr Cardiol       Date:  2016-01       Impact factor: 3.327

5.  Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.

Authors:  Antoine Kossaify; Annie Garcia; Sami Succar; Antoine Ibrahim; Nicolas Moussallem; Mikhael Kossaify; Gilles Grollier
Journal:  Biomark Insights       Date:  2013-09-03

6.  A New Risk Score for Patients With Acute Chest Pain and Normal High Sensitivity Troponin.

Authors:  Chunpeng Ma; Xiaoli Liu; Lixiang Ma
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.